Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$14.61 USD
+0.20 (1.38%)
Updated Aug 23, 2024 03:49 PM ET
After-Market: $14.40 -0.21 (-1.44%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Earnings News For ASMB
-
Assembly Biosciences: Q2 Earnings Snapshot
-
Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
-
Assembly Biosciences: Q1 Earnings Snapshot
-
Assembly Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
-
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
-
Assembly Biosciences: Q3 Earnings Snapshot
-
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
-
Assembly Biosciences: Q2 Earnings Snapshot
-
Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates
-
Assembly Biosciences: Q1 Earnings Snapshot
-
Assembly Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights
-
Assembly Biosciences Provides Update on its Core Inhibitor Pipeline, Reports Fourth Quarter and Year End 2022 Financial Results and Recent Highlights
-
Assembly Biosciences: Q3 Earnings Snapshot
-
Assembly Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights and Announces Upcoming Conference Participation
-
Assembly Biosciences: Q2 Earnings Snapshot
-
Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights
-
Assembly Biosciences (ASMB) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate Assembly Biosciences (ASMB) to Report a Decline in Earnings: What to Look Out for
-
Assembly Biosciences (ASMB) Reports Q1 Loss, Lags Revenue Estimates
-
Earnings Preview: Assembly Biosciences (ASMB) Q1 Earnings Expected to Decline
-
Assembly Biosciences (ASMB) Reports Q4 Loss, Lags Revenue Estimates
-
Will Assembly Biosciences (ASMB) Report Negative Q4 Earnings? What You Should Know
-
Assembly Biosciences (ASMB) Reports Q3 Loss, Tops Revenue Estimates
-
Will Assembly Biosciences (ASMB) Report Negative Q3 Earnings? What You Should Know
-
Assembly Biosciences (ASMB) Surpasses Q2 Earnings and Revenue Estimates